Detection within a Neuroendocrine Tumor of High Levels of B-Lymphocyte Stimulator (BLyS) Correlates with a Greater Disease Severity
#1325
Introduction: .
Aim(s): Potential prognostic role of cytokine B-Lymphocyte Stimulator (BLyS) in follow-up of NET patients.
Materials and methods: 124 unselected patients (disease duration 5.9±4.4 yrs) with NET: 36 lung NET, 47 gastrointestinal NET and 41 pancreatic lesions. In 23 cases BLyS was repeatedly assessed during follow-up, the disease was monitored according to RECIST criteria. Patients were compared with a group of 77 healthy blood donors, matched for age and sex. Serum levels of BLyS and CgA were analyzed using ELISA.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Grimaldi F, Motta C, Cipri C, Tonelli V, Pistis C,
Keywords: Tumor marker,
To read the full abstract, please log into your ENETS Member account.